Evercore ISI raised the firm’s price target on West Pharmaceutical (WST) to $390 from $320 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical Lifts Outlook After Powerful Q1
- Early notable gainers among liquid option names on April 23rd
- Morning Movers: Texas Instruments, Comcast surge after quarterly results
- West Pharmaceutical Raises 2026 Outlook After Strong Quarter
- West Pharmaceutical sees Q2 adjusted EPS $2.05-$2.12, consensus $2.00